CERC - Cerecor Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Cerecor Inc.

540 Gaither Road
Suite 400
Rockville, MD 20850
United States
410-522-8707
http://www.cerecor.com

SectorHealthcare
IndustryBiotechnology
Full Time Employees64

Key Executives

NameTitlePayExercisedYear Born
Dr. Simon C. Pedder Ph.D.Exec. Chairman20.73kN/A1961
Mr. Joseph M. Miller CPACFO, Principal Exec. Officer, Principal Financial Officer & Sec.388.23kN/A1974
Mr. James Archie Harrell Jr.Chief Commercial Officer433.91kN/A1970
Ms. Mariam E. MorrisConsultant500.6kN/A1968
Dr. Solomon H. SnyderFounder and Chairman of Scientific Advisory BoardN/AN/A1939
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Cerecor Inc., a pharmaceutical company, focuses on pediatric health care. Its lead product portfolio includes prescribed dietary supplements, such as Poly-Vi-Flor and Tri-Vi-Flor; and prescription drugs, such as Millipre, Ulesfia, Karbinal ER, AcipHex Sprinkle, and Cefaclor for oral suspension, as well as Flexichamber a medical device. The company is developing CERC-301, an orphan neurological indication for controlling neurologic adaptation; CERC-406 for the treatment of Parkinson's disease; CERC-425, an orally active small molecule; CERC-611, a drug candidate for the treatment of partial-onset seizures in epilepsy; and CERC-913, a protide nucleotide for the treatment of mitochondrial disorder. It also developing preclinical therapies CERC-801, CERC-802, and CERC-803 for the treatment of inherited metabolic disorders. The company was formerly known as Ceregen Corporation and changed its name to Cerecor Inc. in March 2011. Cerecor Inc. was founded in 2011 and is headquartered in Rockville, Maryland.

Corporate Governance

Cerecor Inc.’s ISS Governance QualityScore as of October 4, 2019 is 10. The pillar scores are Audit: 5; Board: 10; Shareholder Rights: 5; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.